110084-95-2

Basic information

• Product Name: H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2
• Synonyms: DES-HIS1-[GLU9]-GLUCAGON (1-29) AMIDE;(DES-HIS1,GLU9)-GLUCAGON (1-29) AMIDE (HUMAN, BOVINE, PORCINE);DES-HIS1,[GLU9]-GLUCAGON AMIDE;H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2;SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2;des-his(1)-glucagonamid;glucagon amide, des-His(1)-;[Des-His1,Glu9]Glucagon (1-29) amide (human)
• CAS NO: 110084-95-2
• Molecular Formula: C148H221N41O47S
• Molecular Weight: 3358.65
• Product Categories: Gastrointestinal Peptides;Glucagons;Peptides for Cell Biology;Glucagon receptor and related;peptide
• Mol File: 110084-95-2.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.52±0.1 g/cm3(Predicted)
• Storage Temp.: −20°C
• CAS DataBase Reference: H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2(CAS DataBase Reference)
• NIST Chemistry Reference: H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2(110084-95-2)
• EPA Substance Registry System: H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2(110084-95-2)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 110084-95-2(Hazardous Substances Data)

Usage

Description

H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2 is a peptide antagonist of the glucagon receptor/adenylyl cyclase system.

Uses

Used in Pharmaceutical Industry:
H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2 is used as a therapeutic agent for regulating glucose homeostasis and treating conditions related to hyperglycemia.
Used in Research and Development:
H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2 is used as a research tool for studying the role of glucagon receptor/adenylyl cyclase system in various physiological processes and disease mechanisms.
Used in Drug Design and Development:
H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2 serves as a lead compound for the development of new drugs targeting the glucagon receptor/adenylyl cyclase system, potentially leading to novel treatments for diabetes and other related conditions.